Skip to main content
Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV
  • Rachel J. Derscheid, Iowa State University
  • Jack M. Gallup, Iowa State University
  • Cory J. Knudson, University of Iowa
  • Steven M. Varga, University of Iowa
  • Drew D. Grosz, Iowa State University
  • Albert G. Van Geelen, Iowa State University
  • Shannon Jones Hostetter, Iowa State University
  • Mark R. Ackermann, Iowa State University
Document Type
Publication Date
Respiratory syncytial virus (RSV) is the most frequent cause of bronchiolitis in infants and children worldwide. There are currently no licensed vaccines or effective antivirals. The lack of a vaccine is partly due to increased caution following the aftermath of a failed clinical trial of a formalin-inactivated RSV vaccine (FI-RSV) conducted in the 1960’s that led to enhanced disease, necessitating hospitalization of 80% of vaccine recipients and resulting in two fatalities. Perinatal lamb lungs are similar in size, structure and physiology to those of human infants and are susceptible to human strains of RSV that induce similar lesions as those observed in infected human infants. We sought to determine if perinatal lambs immunized with FI-RSV would develop key features of vaccine-enhanced disease. This was tested in colostrum-deprived lambs immunized at 3–5 days of age with FI-RSV followed two weeks later by RSV infection. The FI-RSV-vaccinated lambs exhibited several key features of RSV vaccine-enhanced disease, including reduced RSV titers in bronchoalveolar lavage fluid and lung, and increased infiltration of peribronchiolar and perivascular lymphocytes compared to lambs either undergoing an acute RSV infection or naïve controls; all features of RSV vaccine-enhanced disease. These results represent a first step proof-of-principle demonstration that the lamb can develop altered responses to RSV following FI-RSV vaccination. The lamb model may be useful for future mechanistic studies as well as the assessment of RSV vaccines designed for infants.

This article is from PLOS ONE 8 (2013): e81472, doi:10.1371/journal.pone.0081472.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Copyright Owner
Derscheid et al.
File Format
Citation Information
Rachel J. Derscheid, Jack M. Gallup, Cory J. Knudson, Steven M. Varga, et al.. "Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV" PLOS ONE Vol. 8 Iss. 12 (2013) p. e81472
Available at: